Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas

Journal of Neuro-Oncology

Volumn 89, Issue 2, 2008, Pages 205-210

  Combs, Stephanie E ^a   Bischof, Marc ^a   Welzel, Thomas ^a   Hof, Holger ^a   Oertel, Susanne ^a   Debus, Jürgen ^a   Schulz Ertner, Daniela ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Astrocytoma; Chemotherapy; Glioma; Radiotherapy; Recurrence

Indexed keywords

ALIZAPRIDE; CARMUSTINE; METOCLOPRAMIDE; NIMUSTINE; ONDANSETRON; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADJUVANT THERAPY; ADULT; ALOPECIA; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; GERMANY; GLIOMA; HEADACHE; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HOSPITAL DEPARTMENT; HUMAN; MALE; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECURRENT CANCER; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME; TREATMENT PLANNING; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; DACARBAZINE; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; SURVIVAL ANALYSIS;

EID: 48749133554     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9607-4     Document Type: Article

References (23)

1. Dirks P, Bernstein M, Muller PJ, Tucker WS (1993) The value of reoperation for recurrent glioblastoma. Can J Surg 36:271-275
2. Harsh GR, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB (1987) Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615-621
3. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS et al (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17:2762-2771
4. Wick A, Felsberg J, Steinbach JP, Herrlinger U, Platten M, Blaschke B et al (2007) Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. J Clin Oncol 25:3357-3361
5. Bauman GS, Sneed PK, Wara WM, Stalpers LJ, Chang SM, McDermott MW et al (1996) Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 36:433-441
6. Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D (2005) Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol 23:8863-8869
7. Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D (2005) Stereotactic radiosurgery (SRS): Treatment option for recurrent glioblastoma multiforme (GBM). Cancer 104:2168-2173
8. Stupp R, Mason WP, Van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
9. Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L et al (2005) Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlenther Onkol 181:372-377
10. Arcicasa M, Roncadin M, Bidoli E, Dedkov A, Gigante M, Trovo MG (1999) Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 43:789-793
11. Wurm RE, Kuczer DA, Schlenger L, Matnjani G, Scheffler D, Cosgrove VP et al (2006) Hypofractionated stereotactic radiotherapy combined with topotecan in recurrent malignant glioma. Int J Radiat Oncol Biol Phys 66:S26-S32
12. Glass J, Silverman CL, Axelrod R, Corn BW, Andrews DW (1997) Fractionated stereotactic radiotherapy with cis-platinum radiosensitization in the treatment of recurrent, progressive, or persistent malignant astrocytoma. Am J Clin Oncol 20:226-229
13. Lederman G, Wronski M, Arbit E, Odaimi M, Wertheim S, Lombardi E et al (2000) Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol 23:155-159
14. Menke M, Hirschfeld F, Mack T, Pastyr O, Sturm V, Schlegel W (1994) Photogrammetric accuracy measurements of head holder systems used for fractionated radiotherapy. Int J Radiat Oncol Biol Phys 29:1147-1155
15. Schulz-Ertner D, Frank C, Herfarth KK, Rhein B, Wannenmacher M, Debus J (2002) Fractionated stereotactic radiotherapy for craniopharyngiomas. Int J Radiat Oncol Biol Phys 54:1114-1120
16. Clark TG, Bradburn MJ, Love SB, Altman DG (2003) Survival analysis part IV: Further concepts and methods in survival analysis. Br J Cancer 89:781-786
17. Clark TG, Bradburn MJ, Love SB, Altman DG (2003) Survival analysis part I: Basic concepts and first analyses. Br J Cancer 89:232-238
18. Park I, Tamai G, Lee MC, Chuang CF, Chang SM, Berger MS et al. (2007) Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings. Int J Radiat Oncol Biol Phys
19. Sneed PK, Gutin PH, Larson DA, Malec MK, Phillips TL, Prados MD et al (1994) Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 29:719-727
20. Brandes AA, Fiorentino MV (1996) The role of chemotherapy in recurrent malignant gliomas: An overview. Cancer Invest 14:551-559
21. Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD et al (2000) A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 83:588-593
22. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B et al (2006) Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/ 22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24:2563-2569
23. Franceschi E, Omuro AM, Lassman AB, Demopoulos A, Nolan C, Abrey LE (2005) Salvage temozolomide for prior temozolomide responders. Cancer 104:2473-2476